One-Step vs. Two-Step RT-qPCR
By Dr. Zubair Khalid, DVM, MS, PhD ·

Quick Answer
- One-step RT-qPCR combines reverse transcription and PCR amplification in a single reaction, while two-step RT-qPCR separates these processes into distinct reactions.
- Choose one-step for high-throughput screening of many samples against few targets, and two-step when you need flexibility to test multiple genes from the same cDNA stock.
- Both formats require careful primer design, appropriate controls, and standardized reporting to produce reproducible results, and neither format automatically guarantees accuracy.
Understanding the Core Difference
The fundamental distinction between one-step and two-step RT-qPCR lies in the physical separation of the two enzymatic processes. Reverse transcription converts RNA into complementary DNA using a reverse transcriptase enzyme, and quantitative PCR subsequently amplifies that cDNA with a DNA polymerase. In a one-step format, both enzymes operate in the same tube, and the thermal cycler program transitions directly from the reverse transcription temperature to the PCR denaturation temperature. In a two-step format, the reverse transcription reaction completes first, and the resulting cDNA becomes a stable template that can be stored, diluted, and distributed across multiple PCR reactions.
The choice between these formats affects experimental design at the level of sample handling, reagent inventory, and data interpretation. Researchers who work with large numbers of samples and a limited number of target genes often prefer the one-step format because it reduces pipetting steps and minimizes the risk of contamination. Researchers who need to measure many genes from a single biological sample prefer the two-step format because the cDNA can be aliquoted and used for multiple reactions. The decision is not about which format is inherently superior but about which format aligns with the specific experimental question, sample availability, and laboratory workflow.
Core Principles of Reverse Transcription
Reverse transcription is the enzymatic conversion of RNA into complementary DNA. This process requires a reverse transcriptase enzyme, deoxynucleotide triphosphates, a primer, and a suitable buffer. The primer can be an oligo(dT) primer that anneals to the poly(A) tail of messenger RNA, random hexamers that anneal throughout the RNA molecule, or a gene-specific primer that anneals to a particular sequence. The choice of primer affects which RNA molecules are converted into cDNA and therefore influences the downstream measurements.
Oligo(dT) priming selectively converts polyadenylated mRNA, which is useful when studying gene expression. Random hexamers prime throughout the RNA molecule and convert both messenger RNA and other RNA species. Gene-specific primers convert only the RNA of interest, which can be useful when the target is known and the goal is to maximize sensitivity. The choice of priming strategy is a key decision in the two-step format because the cDNA pool is used for multiple downstream reactions. In the one-step format, the primer choice is often dictated by the assay design because the reverse transcription and PCR use the same reaction tube.
The efficiency of reverse transcription depends on the quality of the RNA template, the temperature of the reaction, and the presence of inhibitors. RNA is chemically less stable than DNA and is susceptible to degradation by ribonucleases. The integrity of the RNA template is a primary determinant of the accuracy of the downstream measurement. Laboratories that work with RNA should use ribonuclease-free reagents, wear gloves, and maintain a clean workspace to minimize the risk of degradation.
One-Step RT-qPCR Workflow
The one-step format combines reverse transcription and PCR in a single tube. The reaction contains the RNA template, reverse transcriptase, DNA polymerase, primers, probes, nucleotides, and buffer. The thermal cycling program begins with an incubation step at a temperature that supports reverse transcription, typically around 42 to 50 degrees Celsius. The reaction then moves to a higher temperature that activates the DNA polymerase and inactivates the reverse transcriptase. The subsequent cycles follow the standard PCR pattern of denaturation, annealing, and extension.
The main advantage of the one-step format is the reduced number of handling steps. The RNA sample is added directly to the reaction, and the entire process occurs in a single tube. This reduces the risk of contamination and reduces the amount of pipetting required. The one-step format is well suited for high-throughput screening where many samples are tested against a small number of targets. It is also well suited for diagnostic applications where the goal is to detect the presence or absence of a specific RNA sequence.
The one-step format has limitations. The reaction is a single tube, so the cDNA is not available for additional tests. If the researcher wants to measure multiple genes from the same sample, the one-step format requires a separate reaction for each gene, which consumes more RNA and more reagents. The one-step format also has less flexibility in optimizing the reverse transcription and PCR conditions independently. The reverse transcription step must be compatible with the PCR step, and the buffer composition must support both enzymes.
Two-Step RT-qPCR Workflow
The two-step format separates reverse transcription and PCR into two distinct reactions. The first reaction converts RNA to cDNA using a reverse transcriptase and a primer. The cDNA is then diluted and used as the template for the PCR reaction. The PCR reaction contains the cDNA, DNA polymerase, primers, probes, and buffer. The thermal cycling protocol for the PCR step is the standard PCR pattern.
The main advantage of the two-step format is the flexibility it provides. The cDNA produced in the first reaction is a stable template that can be stored at low temperatures and used for multiple PCR reactions. This is particularly useful when the researcher needs to measure multiple genes from the same biological sample. The cDNA can be aliquoted into multiple tubes, and each tube can be used for a different target gene. The two-step format also allows the researcher to optimize the reverse transcription and PCR conditions independently.
The two-step format has limitations. The additional handling steps increase the risk of contamination and introduce more opportunities for pipetting error. The cDNA produced in the first reaction must be carefully quantified and diluted to ensure that the PCR reactions are consistent. The two-step format also requires more reagents and more time than the one-step format because the two reactions are performed separately.
Sensitivity and Dynamic Range
The sensitivity of an RT-qPCR assay refers to the ability to detect low amounts of the target RNA. The dynamic range refers to the range of target concentrations over which the assay produces a linear response. Both one-step and two-step formats can be sensitive and have a wide dynamic range, but the practical sensitivity depends on the quality of the RNA template, the efficiency of the reverse transcription, and the design of the PCR primers and probes.
In the one-step format, the entire RNA sample is used in a single reaction. This can be an advantage when the RNA is limited because the entire sample is available for the reverse transcription. In the two-step format, the RNA is first converted to cDNA, and then a portion of the cDNA is used for the PCR. This means that the effective amount of RNA in the PCR reaction is reduced by the dilution factor. The researcher can compensate for this by using a larger volume of cDNA in the PCR reaction, but this also increases the amount of the reaction components.
The dynamic range of the assay is determined by the linearity of the amplification across a range of target concentrations. The amplification efficiency should be consistent across the dynamic range, and the standard curve should be linear. The MIQE guidelines recommend that the amplification efficiency be reported and that the standard curve be used to determine the dynamic range. The guidelines also recommend that the limit of detection and the limit of quantification be reported for each assay.
Multiplexing Capabilities
Multiplexing refers to the ability to measure multiple target genes in a single reaction. This is achieved by using different fluorescent dyes that are attached to different probes. Each probe is specific to a different target sequence, and the fluorescence from each dye is measured at a different wavelength. Multiplexing can reduce the number of reactions required and reduce the cost of the experiment.
The one-step format is generally less flexible for multiplexing because the reverse transcription and PCR are performed in the same tube. The reverse transcription step uses a primer that is either oligo(dT), random hexamers, or a gene-specific primer. If the reverse transcription uses a gene-specific primer, the primer is specific to one target, and the multiplexing is limited to the PCR step. If the reverse transcription uses random hexamers or oligo(dT), the cDNA is a pool of all the RNA, and the PCR step can be multiplexed.
The two-step format is more flexible for multiplexing because the cDNA pool is produced in the first reaction and can be used for multiple PCR reactions. The PCR step can be multiplexed by using multiple probes with different dyes. The two-step format also allows the researcher to use the same cDNA pool for multiple single-plex reactions, which can be useful when the target genes have different optimal conditions.
Primer and Probe Design
The design of the primers and probes is a critical determinant of the success of the RT-PCR assay. The primers must be specific to the target gene and must not amplify non-specific products. The probes must be specific to the target gene and must not bind to non-target sequences. The design of the primers and probes is typically done using software that analyzes the target sequence and identifies the optimal primer and probe sequences.
The primers should have a melting temperature that is appropriate for the PCR conditions. The melting temperature of the forward and reverse primers should be similar, and the melting temperature of the probe should be higher than the melting temperature of the primers. The primers should not form secondary structures, and the primers should not form dimers with each other. The probe should not form secondary structures, and the probe should not bind to the primers.
The design of the primers and probes is also affected by the format of the RT-PCR. In the one-step format, the reverse transcription primer is the same as the reverse PCR primer. This means that the reverse primer must be designed to work in both the reverse transcription and the PCR. In the two-step format, the reverse transcription primer can be a random hexamer, an oligo(dT) primer, or a gene-specific primer. The PCR primers are designed separately.
Controls and Standardization
The reliability of an RT-PCR assay depends on the use of appropriate controls. The controls are used to verify that the assay is working correctly and to identify any problems with the reaction. The MIQE guidelines recommend that the following controls be included in each RT-PCR experiment.
A no-template control is a reaction that contains all the components except the RNA template. This control is used to detect contamination of the reagents or the workspace. A no-reverse-transcription control is a reaction that contains the RNA template but not the reverse transcriptase. This control is used to detect the presence of genomic DNA contamination in the RNA sample. A positive control is a reaction that contains a known amount of the target RNA. This control is used to verify that the assay is working correctly.
The use of a standard curve is also recommended. A standard curve is a series of reactions that contain known amounts of the target RNA. The standard curve is used to determine the efficiency of the amplification and the dynamic range of the assay. The standard curve is also used to calculate the amount of the target RNA in the unknown samples.
The MIQE guidelines also recommend that the results of the RT-PCR be reported in a transparent manner. The report should include the number of technical replicates, the number of biological replicates, the standard deviation, and the standard error. The report should also include the amplification efficiency and the correlation coefficient of the standard curve.
Data Analysis and Interpretation
The data from an RT-PCR experiment is the cycle threshold value, which is the cycle number at which the fluorescence signal crosses a threshold. The threshold is set above the background fluorescence and within the exponential phase of the amplification. The cycle threshold value is inversely proportional to the amount of the target RNA in the sample. A lower cycle threshold value indicates a higher amount of the target RNA.
The cycle threshold value is used to calculate the relative amount of the target RNA. The relative amount is calculated by comparing the cycle threshold value of the target gene to the cycle threshold value of a reference gene. The reference gene is a gene that is expressed at a constant level across the samples. The relative expression is calculated using the delta-delta-Ct method or the standard curve method.
The delta-delta-Ct method is a simple method that uses the cycle threshold values of the target and reference genes. The method assumes that the amplification efficiency of the target and reference genes is the same. The standard curve method is a more accurate method that uses the standard curve to calculate the absolute amount of the target RNA. The standard curve method is recommended when the amplification efficiency of the target and reference genes is different.
The interpretation of the RT-PCR results should be done in the context of the experimental design. The results should be compared to the controls and the standard curve. The results should also be compared to the results of the other samples in the experiment. The interpretation should be done by a person who is familiar with the experimental design and the limitations of the assay.
Common Failure Patterns
The most common failure pattern in RT-PCR is the absence of amplification. This can be caused by the degradation of the RNA template, the presence of inhibitors in the sample, or the failure of the reverse transcription. The degradation of the RNA template can be detected by the use of a quality control assay. The presence of inhibitors can be detected by the use of a spike-in control. The failure of the reverse transcription can be detected by the use of a positive control.
Another common failure pattern is the presence of non-specific amplification. This can be caused by the binding of the primers to non-target sequences or the formation of primer dimers. The non-specific amplification can be detected by the use of a melt curve analysis. The melt curve analysis is a method that measures the fluorescence of the reaction as the temperature is increased. The melt curve should show a single peak for the target gene. The presence of multiple peaks indicates the presence of non-specific products.
The presence of genomic DNA contamination is another common failure pattern. This can be caused by the presence of genomic DNA in the RNA sample. The genomic DNA contamination can be detected by the use of a no-reverse-transcription control. The genomic DNA contamination can be removed by the use of a DNase treatment.
Biosafety and Regulatory Context
The use of RT-PCR involves the handling of biological samples and the use of chemical reagents. The biosafety level of the laboratory should be appropriate for the type of samples being handled. The biosafety level is determined by the risk of the biological agents being handled. The CDC and NIH provide guidelines for the biosafety levels in the Biosafety in Microbiological and Biomedical Laboratories. The guidelines describe the practices, safety equipment, and facility design for each biosafety level.
The use of recombinant or synthetic nucleic acid molecules is subject to the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. The guidelines describe the practices for the use of recombinant and synthetic nucleic acid molecules. The guidelines also describe the requirements for the institutional biosafety committee.
The use of RT-PCR also involves the use of chemical reagents, such as the reverse transcriptase and the DNA polymerase. The reagents should be handled according to the safety data sheets. The reagents should be stored according to the manufacturer's instructions. The reagents should be disposed of according to the institutional guidelines.
Practical Decision Framework
The choice between one-step and two-step RT-PCR depends on the experimental goals and the resources available. The following framework can be used to make the decision.
The first consideration is the number of samples. If the number of samples is high, the one-step format is more efficient because it reduces the number of reactions. The one-step format is also more convenient because it reduces the number of pipetting steps. The two-step format is more efficient when the number of samples is low and the number of targets is high.
The second consideration is the number of targets. If the number of targets is low, the one-step format is more efficient. The one-step format is also more convenient when the number of targets is low. The two-step format is more efficient when the number of targets is high because the cDNA can be used for multiple reactions.
The third consideration is the amount of RNA available. If the amount of RNA is limited, the one-step format is more efficient because the entire RNA is used in the reaction. The two-step format is less efficient because the RNA is first converted to cDNA and then a portion of the cDNA is used in the PCR.
The fourth consideration is the need for flexibility. If the researcher needs to measure multiple genes from the same sample, the two-step format is more flexible because the cDNA can be used for multiple reactions. The one-step format is less flexible because the cDNA is not available for additional reactions.
The fifth consideration is the need for sensitivity. If the sensitivity is the primary concern, the one-step format is more sensitive because the entire RNA is used in the reaction. The two-step format is less sensitive because the portion of the cDNA is used in the PCR.
At a Glance
| Feature | One-Step RT-qPCR | Two-Step RT-qPCR |
|---|---|---|
| Workflow | Reverse transcription and PCR in a single tube | Reverse transcription and PCR in separate tubes |
| Sample throughput | Higher throughput for many samples and few targets | Lower throughput for many samples and many targets |
| Flexibility | Lower flexibility for testing multiple genes from one sample | Higher flexibility for testing multiple genes from one sample |
| Multiplexing | Limited by the reverse transcription primer | More flexible for multiplexing in the PCR step |
| RNA requirement | Uses the entire RNA sample in the reaction | Uses a portion of the cDNA in the PCR reaction |
| Contamination risk | Lower risk due to fewer steps | Higher risk due to additional steps |
| Time | Shorter time to result | Longer time to result |
| Cost | Lower cost per reaction | Higher cost per reaction |
Practical Implementation Steps
The following steps provide a practical approach to implementing RT-qPCR in a laboratory.
- Define the experimental question and the target genes.
- Design the primers and probes for the target genes.
- Validate the primers and probes using a standard curve.
- Prepare the RNA samples and verify the quality of the RNA.
- Choose the one-step or two-step format based on the experimental design.
- Set up the reactions according to the manufacturer's instructions.
- Run the reactions on a thermal cycler.
- Analyze the data using the appropriate method.
- Report the results according to the MIQE guidelines.
Records and Measurements
The following records and measurements should be maintained for each RT-qPCR experiment.
- The date of the experiment and the name of the person who performed the experiment.
- The type of the sample and the source of the sample.
- The concentration and the quality of the RNA.
- The primer and probe sequences.
- The thermal cycling protocol.
- The cycle threshold values for each reaction.
- The standard curve data.
- The amplification efficiency and the correlation coefficient.
- The results of the controls.
Common Failure Patterns and Troubleshooting
| Failure Pattern | Possible Cause | Troubleshooting Step |
|---|---|---|
| No amplification | RNA degradation | Check the RNA quality and use a fresh RNA sample |
| No amplification | Reverse transcription failure | Check the reverse transcriptase and the primer |
| No amplification | PCR failure | Check the PCR primers and the probe |
| Non-specific amplification | Primer dimers | Redesign the primers |
| Non-specific amplification | Genomic DNA contamination | Use a no-reverse-transcription control |
| High cycle threshold | Low RNA amount | Use more RNA in the reaction |
| High cycle threshold | Low amplification efficiency | Optimize the primer and probe concentrations |
Professional Escalation Criteria
The following criteria indicate that the RT-PCR results should be reviewed by a more experienced person.
- The results are inconsistent with the expected results.
- The controls do not produce the expected results.
- The standard curve is not linear.
- The amplification efficiency is outside the acceptable range.
- The results are not reproducible.
A Practical Decision Framework for Matching RT-qPCR Format to Laboratory Workflow
The choice between one-step and two-step RT-qPCR is often presented as a simple tradeoff between convenience and flexibility, but the decision becomes clearer when you map your specific laboratory workflow against measurable operational factors. This framework moves beyond general preferences and provides a structured method for evaluating your experimental pipeline, estimating reagent consumption, and identifying the format that minimizes error and cost for your particular situation.
Step 1: Inventory Your Sample and Target Matrix
Before choosing a format, create a concrete inventory of your experimental pipeline. Count the number of biological samples you process per experiment and the number of target genes you measure per sample. This sample-target matrix is the single most important determinant of format choice.
For a matrix with many samples and few targets, the one-step format reduces total reaction count. If you have 96 samples and measure one target, the one-step format requires 96 reactions. The two-step format requires one reverse transcription reaction per sample followed by 96 PCR reactions, which is 192 total reactions. The one-step format halves the reaction count and the associated reagent cost.
For a matrix with few samples and many targets, the two-step format becomes more efficient. If you have 10 samples and measure 20 targets, the one-step format requires 200 reactions. The two-step format requires 10 reverse transcription reactions plus 200 PCR reactions, but the cDNA from each reverse transcription can be diluted and distributed across the 20 PCR reactions. The two-step format also preserves the cDNA stock for future experiments, which is valuable when samples are irreplaceable.
The crossover point occurs when the number of samples multiplied by the number of targets exceeds the practical capacity of your laboratory. A laboratory that processes 50 samples per week with 5 targets per sample can manage 250 reactions per week in either format. A laboratory that processes 200 samples per week with 10 targets per sample faces 2000 reactions per week, and the one-step format becomes operationally difficult because each reaction requires a separate tube and pipetting event.
Step 2: Assess RNA Availability and Quality Constraints
The amount of RNA available per sample is a limiting factor that often overrides convenience considerations. The one-step format uses the entire RNA sample in a single reaction, which is advantageous when RNA is scarce. The two-step format requires that the reverse transcription reaction produce enough cDNA for multiple PCR reactions, which means the RNA input must be sufficient to support the downstream dilution.
A practical rule is to measure the RNA concentration and calculate the total RNA available per sample. If the total RNA is below 100 nanograms, the one-step format is the safer choice because it avoids the loss that occurs during cDNA dilution. If the total RNA exceeds 500 nanograms, the two-step format provides enough cDNA for multiple reactions without compromising sensitivity.
RNA quality is equally important. The one-step format is more forgiving of minor RNA degradation because the reverse transcription and PCR occur in the same tube, and the reverse transcriptase can synthesize cDNA from partially degraded templates. The two-step format requires that the RNA survive the reverse transcription reaction and the subsequent storage and handling steps. If your RNA samples have a RIN value below 7, the one-step format reduces the risk of degradation during the additional handling steps.
Step 3: Evaluate the Need for Multiplexing
Multiplexing is the measurement of multiple targets in a single reaction using different fluorescent dyes. The two-step format is more flexible for multiplexing because the cDNA pool is produced in the first reaction and can be used for multiple PCR reactions. The PCR step can be multiplexed by using multiple probes with different dyes.
The one-step format is less flexible for multiplexing because the reverse transcription and PCR are performed in the same tube. If the reverse transcription uses a gene-specific primer, the primer is specific to one target, and the multiplexing is limited to the PCR step. If the reverse transcription uses random hexamers or oligo(dT), the cDNA is a pool of all the RNA, and the PCR step can be multiplexed.
The decision to multiplex depends on the number of targets and the availability of compatible probes. Multiplexing reduces the number of reactions and the cost of the experiment, but it requires careful design of the probes to avoid cross-reactivity and to ensure that the fluorescent signals do not overlap. The MIQE guidelines recommend that the multiplexing strategy be reported in the experimental methods.
Step 4: Calculate the Total Cost Per Sample
The cost per sample is a function of the number of reactions, the reagent cost per reaction, and the labor cost per reaction. The one-step format has a lower reagent cost per reaction because it uses a single reaction tube and a single set of reagents. The two-step format has a higher reagent cost per reaction because it requires a separate reverse transcription reaction and a separate PCR reaction.
The labor cost is also a factor. The one-step format requires fewer pipetting steps and less time to set up. The two-step format requires additional pipetting steps and more time to set up. The labor cost is higher for the two-step format, but the cost is offset by the flexibility of the cDNA pool.
A practical cost calculation is to estimate the total cost per sample for each format. The one-step format cost is the reagent cost per reaction multiplied by the number of targets. The two-step format cost is the reverse transcription reagent cost plus the PCR reagent cost multiplied by the number of targets. The two-step format is more expensive per sample when the number of targets is low, but the cost per target decreases as the number of targets increases.
Step 5: Consider the Time to Result
The time to result is the time from the start of the experiment to the final data analysis. The one-step format has a shorter time to result because the reverse transcription and PCR are performed in the same tube. The two-step format has a longer time to result because the reverse transcription and PCR are performed in separate tubes, and the cDNA is stored and diluted before the PCR.
The time to result is important for diagnostic applications where the goal is to detect the presence or absence of a specific RNA sequence. The one-step format is preferred for diagnostic applications because it reduces the time to result and the risk of contamination. The two-step format is preferred for research applications where the goal is to measure multiple genes from the same sample.
Step 6: Document the Decision in a Laboratory Record
The decision between one-step and two-step RT-qPCR should be documented in the laboratory record. The record should include the sample matrix, the RNA availability, the number of targets, the cost calculation, and the time to result. The record should also include the rationale for the decision and the expected outcomes.
The laboratory record is a critical component of the quality system. The record provides a basis for the review of the experimental design and the interpretation of the results. The record also provides a basis for the troubleshooting of the assay if the results are not reproducible.
Step 7: Review the Decision at Regular Intervals
The decision between one-step and two-step RT-qPCR should be reviewed at regular intervals. The review should consider the changes in the sample matrix, the RNA availability, the number of targets, and the cost of the reagents. The review should also consider the changes in the laboratory workflow and the availability of new reagents.
The review should be documented in the laboratory record. The review should include the date of the review, the name of the person who performed the review, and the outcome of the review. The review should also include the recommendation for the future experiments.
A Worked Example of the Decision Framework
Consider a laboratory that studies gene expression in tissue samples. The laboratory processes 50 samples per week and measures 10 target genes per sample. The RNA yield is 200 nanograms per sample, and the RNA quality is good with a RIN value of 8.
The sample matrix is 50 samples and 10 targets. The one-step format requires 500 reactions per week. The two-step format requires 50 reverse transcription reactions plus 500 PCR reactions, which is 550 total reactions. The one-step format is more efficient in terms of the number of reactions.
The RNA availability is 100 nanograms per sample. The one-step format uses the entire RNA sample in a single reaction. The two-step format requires that the RNA be converted to cDNA and then a portion of the cDNA is used for the PCR. The one-step format is more efficient in terms of the RNA usage.
The number of targets is 10. The two-step format is more flexible because the cDNA can be used for multiple PCR reactions. The one-step format is less flexible because the cDNA is not available for additional reactions.
The cost per sample is the reagent cost per reaction multiplied by the number of targets. The one-step format has a lower cost per reaction. The two-step format has a higher cost per reaction. The cost per sample is lower for the one-step format when the number of targets is low.
The time to result is shorter for the one-step format. The one-step format is preferred for the diagnostic applications. The two-step format is preferred for the research applications.
The decision is to use the one-step format for the high-throughput screening and the two-step format for the research applications. The decision is documented in the laboratory record and reviewed at regular intervals.
Common Failure Patterns in the Decision Process
The most common failure pattern in the decision process is the use of the one-step format for the research applications that require the measurement of multiple genes from the same sample. The one-step format is not flexible enough for the multiplexing and the multiple gene measurement. The two-step format is more flexible for the multiple gene measurement.
Another common failure pattern is the use of the two-step format for the high-throughput screening. The two-step format is not efficient for the high-throughput screening because it requires the additional reverse transcription reactions and the additional pipetting steps. The one-step format is more efficient for the high-throughput screening.
The third common failure pattern is the use of the one-step format for the diagnostic applications that require the detection of the presence or absence of a specific RNA sequence. The one-step format is preferred for the diagnostic applications because it provides the shorter time to result and the lower risk of the contamination.
Professional Escalation Criteria for the Decision Process
The following criteria indicate that the decision process should be reviewed by a more experienced person.
- The sample matrix is not clear or the number of samples and the number of targets are not defined.
- The RNA availability is not sufficient for the chosen format.
- The cost per the sample is not within the budget.
- The time to the result is not within the required.
- The validation of the chosen format is not complete.
The review should be performed by a person who is familiar with the experimental design and the limitations of the assay. The review should include the recommendation of the format and the rationale for the recommendation. The review should also include the documentation of the decision and the validation of the chosen format.
Frequently Asked Questions
What is the main difference between one-step and two-step RT-qPCR?
The main difference is the number of reactions. One-step RT-qPCR combines reverse transcription and PCR in a single tube, while two-step RT-qPCR performs reverse transcription and PCR in separate tubes.
Which format is more sensitive?
The one-step format is generally more sensitive because the entire RNA sample is used in the reverse transcription reaction. The two-step format uses a portion of the cDNA in the PCR reaction, which can reduce the sensitivity.
Which format is more flexible?
The two-step format is more flexible because the cDNA can be used for multiple PCR reactions. This is useful when the researcher needs to measure multiple genes from the same sample.
Which format is better for multiplexing?
The two-step format is better for multiplexing because the cDNA can be used for multiple PCR reactions. The one-step format is less flexible for multiplexing because the reverse transcription and PCR are combined in the same reaction.
Which format is better for high-throughput screening?
The one-step format is better for high-throughput screening because it reduces the number of reactions and the number of pipetting steps. This is useful when the researcher needs to process many samples against a few targets.
How do I choose between one-step and two-step RT-qPCR?
The choice depends on the experimental goals. The one-step format is better for high-throughput screening and when the amount of RNA is limited. The two-step format is better for measuring multiple genes from the same sample and for multiplexing.
What controls should I include in an RT-qPCR experiment?
The controls should include a no-template control, a no-reverse-transcription control, and a positive control. The no-template control is used to detect contamination. The no-reverse-transcription control is used to detect genomic DNA contamination. The positive control is used to verify that the assay is working correctly.
What is the MIQE guideline?
The MIQE guideline is a set of recommendations for the reporting of qPCR experiments. The guideline recommends that the use of the controls, the standard curve, and the reporting of the results be done in a transparent manner. The guideline is published in the journal Clinical Chemistry and is available at MIQE Guidelines.
qPCR Copy Number Calculator
Use this calculation as a check on recorded inputs and method-specific assumptions. It does not replace assay validation, quality controls, or professional interpretation.
Related Molecular Biology Guides
- Difference Between PCR and qPCR: Key Concepts Explained
- Differential Gene Expression Analysis in R: A Practical Guide
- Differential Gene Expression Analysis with DESeq2: A Practical Guide
- Gene Imprinting: How One Parent's Gene Wins the Expression Battle
- Differential Gene Expression (DGE) Analysis: Methods and Pitfalls
References and Further Reading
- Molecular Biology and Laboratory Methods. National Library of Medicine.
- Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
- NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
- Addgene Protocols. Addgene.
- MIQE Guidelines. Clinical Chemistry.
- NIST Laboratory Programs. National Institute of Standards and Technology.
- Monitoring SARS-CoV-2 in sewage: Toward sentinels with analytical accuracy.. The Science of the total environment, 2022.
- An Exploratory Search for Potential Molecular Targets Responsive to the Probiotic Lactobacillus salivarius PS2 in Women With Mastitis: Gene Expression Profiling vs. Interindividual Variability.. Frontiers in microbiology, 2018.
- Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples.. 2026.
- Development of Chimeric Ribonuclease A Inhibitor for Molecular Biology Applications: SUMO Fusion as an Engineering Strategy. 2026.
- Analytical performance evaluation and method comparison of the 1copy BCR::ABL1 qPCR assay for monitoring chronic myeloid leukemia.. 2026.
This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.